ออฟไลน์ด้วยแอป Player FM !
From Biotech Breakthroughs to Food Tech Revolution: Dr. Ron Shigeta's Journey
Fetch error
Hmmm there seems to be a problem fetching this series right now. Last successful fetch was on November 18, 2024 13:18 ()
What now? This series will be checked again in the next day. If you believe it should be working, please verify the publisher's feed link below is valid and includes actual episode links. You can contact support to request the feed be immediately fetched.
Manage episode 426573631 series 3535889
Summary
Dr. Ron Shigeta, a pioneer in the biotech startup ecosystem, shares his insights and experiences in this episode. He discusses the success of IndieBio, a biotech accelerator that demonstrated the potential of modest investments in fueling biotech innovations.
Dr. Shigeta also highlights the importance of timing, luck, and having a clear vision in the biotech industry. He explains the differences between synthetic biology and pharma startups and the challenges and opportunities they present.
Additionally, he discusses the factors he considers when evaluating startup opportunities and the mindset of successful entrepreneurs. Finally, he shares his perspective on managing risk in biotech startups and the personal transition of becoming a startup CEO. In this conversation, Ron Shigeta discusses the landscape of venture capital funds and startup incubators, highlighting the importance of fund size and check-writing capabilities. He also explains his attraction to the food industry and the deep structural biology of food. The convergence of food and biotech is explored, with a focus on consumer applications and health-related applications. Ron shares different strategies for innovation and offers advice for aspiring entrepreneurs. He discusses promising areas for transformational impact, including the golden age of biology and the future of food and sustainability.
Chapters
00:00 Introduction to Dr. Ron Shigeta
01:31 Dr. Shigeta's transition from scientist to biotech startup figure
05:19 The impact of IndieBio's small investment model
08:43 The economics of biotech startups
09:57 Different pathways in biotech: synthetic biology vs. pharma
13:42 Factors in evaluating startup opportunities
14:09 The mindset of successful entrepreneurs
19:35 The importance of company vision and team dynamics
22:23 Managing risk in biotech startups
27:28 The personal transition of becoming a startup CEO
31:23 The risk tolerance of entrepreneurs
32:36 Venture Capital Funds and Startup Incubators
37:15 The Attraction of the Food Industry
42:30 Convergence of Food and Biotech
46:12 Innovation in Biotech and Pharma
49:37 Different Strategies for Innovation
51:42 Advice for Aspiring Entrepreneurs
53:47 Promising Areas for Transformational Impact
01:01:26 The Golden Age of Biology
01:04:51 The Impact of Whole Foods Conference
01:08:49 The Future of Food and Sustainability
Resources:
25 ตอน
Fetch error
Hmmm there seems to be a problem fetching this series right now. Last successful fetch was on November 18, 2024 13:18 ()
What now? This series will be checked again in the next day. If you believe it should be working, please verify the publisher's feed link below is valid and includes actual episode links. You can contact support to request the feed be immediately fetched.
Manage episode 426573631 series 3535889
Summary
Dr. Ron Shigeta, a pioneer in the biotech startup ecosystem, shares his insights and experiences in this episode. He discusses the success of IndieBio, a biotech accelerator that demonstrated the potential of modest investments in fueling biotech innovations.
Dr. Shigeta also highlights the importance of timing, luck, and having a clear vision in the biotech industry. He explains the differences between synthetic biology and pharma startups and the challenges and opportunities they present.
Additionally, he discusses the factors he considers when evaluating startup opportunities and the mindset of successful entrepreneurs. Finally, he shares his perspective on managing risk in biotech startups and the personal transition of becoming a startup CEO. In this conversation, Ron Shigeta discusses the landscape of venture capital funds and startup incubators, highlighting the importance of fund size and check-writing capabilities. He also explains his attraction to the food industry and the deep structural biology of food. The convergence of food and biotech is explored, with a focus on consumer applications and health-related applications. Ron shares different strategies for innovation and offers advice for aspiring entrepreneurs. He discusses promising areas for transformational impact, including the golden age of biology and the future of food and sustainability.
Chapters
00:00 Introduction to Dr. Ron Shigeta
01:31 Dr. Shigeta's transition from scientist to biotech startup figure
05:19 The impact of IndieBio's small investment model
08:43 The economics of biotech startups
09:57 Different pathways in biotech: synthetic biology vs. pharma
13:42 Factors in evaluating startup opportunities
14:09 The mindset of successful entrepreneurs
19:35 The importance of company vision and team dynamics
22:23 Managing risk in biotech startups
27:28 The personal transition of becoming a startup CEO
31:23 The risk tolerance of entrepreneurs
32:36 Venture Capital Funds and Startup Incubators
37:15 The Attraction of the Food Industry
42:30 Convergence of Food and Biotech
46:12 Innovation in Biotech and Pharma
49:37 Different Strategies for Innovation
51:42 Advice for Aspiring Entrepreneurs
53:47 Promising Areas for Transformational Impact
01:01:26 The Golden Age of Biology
01:04:51 The Impact of Whole Foods Conference
01:08:49 The Future of Food and Sustainability
Resources:
25 ตอน
ทุกตอน
×ขอต้อนรับสู่ Player FM!
Player FM กำลังหาเว็บ